Moderna Soars After $483 Million Covid-19 Agreement With U.S.
A research associate works at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S. (Photographer: Adam Glanzman/Bloomberg)

Moderna Soars After $483 Million Covid-19 Agreement With U.S.

(Bloomberg) -- Moderna Inc. shares rose as much as 21% after the company said the U.S. government has agreed to pay as much as $483 million for the company to develop and test its Covid-19 vaccine ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.